Press Releases
- TGA registration of Exdensur (depemokimab) offers a new treatment option for Australians living with severe asthma
- Older Australians recognise RSV can be serious, but many don't consider it a personal risk, new research suggests
- GSK Australia wins Great Place To Work® Certification
